179 related articles for article (PubMed ID: 4380581)
41. Dermatological complications of peripheral vascular disease.
McCallum DI
Practitioner; 1971 Mar; 206(233):359-67. PubMed ID: 4396666
[No Abstract] [Full Text] [Related]
42. [Therapeutic use of chloroquine. (Review)].
De Carlo M; Russo V
Arch Ital Sci Med Trop Parassitol; 1970; 51(7):97-121. PubMed ID: 4402155
[No Abstract] [Full Text] [Related]
43. [On the use of cytostatic drugs in dermatology].
Knoth W
Ther Umsch; 1969 Feb; 26(2):89-93. PubMed ID: 5771454
[No Abstract] [Full Text] [Related]
44. [Role of histamine in compensation for microcirculatory disorders in systemic lupus erythematosus and systemic allergic vasculitis].
Potekhina RN; Poltyrev AS; Shilkina NP; Alekseev VI
Vopr Revm; 1979; (2):15-20. PubMed ID: 37651
[No Abstract] [Full Text] [Related]
45. [Respiratory manifestatioins of collagenosis. General review].
CHENEBAULT J
Maroc Med; 1962 Oct; 41():979-90. PubMed ID: 14020532
[No Abstract] [Full Text] [Related]
46. [Effect of andecalin therapy on skin blood supply in patients with scleroderma and chronic lupus erythematosus].
Sbitneva EP; Zhidkov IL; Vinitskiĭ LI
Vestn Dermatol Venerol; 1979 Feb; (2):63-7. PubMed ID: 425691
[No Abstract] [Full Text] [Related]
47. Diseases of the dermis. General considerations.
Achten G
Arch Belg Dermatol Syphiligr; 1972; 28(1):1-13. PubMed ID: 4656304
[No Abstract] [Full Text] [Related]
48. [Hair changes in immunosuppressive therapy].
Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J
Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252
[No Abstract] [Full Text] [Related]
49. Adrenal steroid therapy in neurological disease. Part I.
Eisen AA; Norris JW
Can Med Assoc J; 1969 Jan; 100(1):27-30. PubMed ID: 4388115
[No Abstract] [Full Text] [Related]
50. [Immunosuppressive therapy].
Miescher PA; Gerebtzoff A; Lambert PH
Ergeb Inn Med Kinderheilkd; 1974; 34(0):1-22. PubMed ID: 4154072
[No Abstract] [Full Text] [Related]
51. [Immunosuppressant drugs in dermatology (author's transl)].
Christeler A; Delacrétaz J
Ther Umsch; 1979 May; 36(5):456-62. PubMed ID: 451959
[No Abstract] [Full Text] [Related]
52. [The clinical significance of study of autoimmune processes in systemic lupus erythematosus and various other collagenoses].
Ivanova AV; Selivanova IA
Ter Arkh; 1968 Aug; 40(8):66-70. PubMed ID: 4393756
[No Abstract] [Full Text] [Related]
53. [Use of immunosuppressive agents in systemic diseases].
Bétourné C
Sem Hop; 1977 Jun; 53(24):1472-5. PubMed ID: 19844
[TBL] [Abstract][Full Text] [Related]
54. [M scleroderma (with systemic progressive sclerosis) associated with clinical and biological signs of dermatomyositis and lupus erythematosus].
Grupper C; Durepaire RM; Eisenmann D; Briche R
Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):219-20. PubMed ID: 4642837
[No Abstract] [Full Text] [Related]
55. [Complexons in the treatment of lupus erythematosus].
Glavinskaia TA; Grube SB; Pavlova LT; Shutov AN
Vestn Dermatol Venerol; 1980 Dec; (12):24-8. PubMed ID: 7010826
[No Abstract] [Full Text] [Related]
56. [Immunosuppressive therapy of lupoid hepatitis].
Ota Y
Nihon Rinsho; 1970 Jul; 28(7):1892-9. PubMed ID: 4196108
[No Abstract] [Full Text] [Related]
57. Therapy for connective tissue disease.
Smith EA; Leroy EC
Compr Ther; 1986 Sep; 12(9):24-9. PubMed ID: 3769420
[No Abstract] [Full Text] [Related]
58. [The application and value of immunofluorescence procedures in dermatology (author's transl)].
Holubar K
Wien Klin Wochenschr; 1974 Jun; 86(12):325-30. PubMed ID: 4599929
[No Abstract] [Full Text] [Related]
59. Intradermal tests with autologous white blood cells in chronic discoid lupus erythematosus and other skin diseases.
Czernielewski A; Wranicz A
Pathol Eur; 1966; 1(1):262-7. PubMed ID: 4384233
[No Abstract] [Full Text] [Related]
60. [Antimetabolites in complex treatment of systemic lupus erythematosus in children].
Isaeva LA; Kartasheva VI
Pediatriia; 1974 Nov; (11):40-8. PubMed ID: 4444879
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
